Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05338294

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Northern Jiangsu People's Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.

Detailed description

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy and azygoportal disconnection, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the immune function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including the counts of leukocytes, neutrophils, lymphocytes, and monocytes, and the levels of CD4+,CD8+,CD4+/CD8+, and CD19,CD20.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic splenectomy and azygoportal disconnectionLaparoscopic splenectomy and azygoportal disconnection is performed by the same surgical team.

Timeline

Start date
2022-03-01
Primary completion
2025-07-31
Completion
2025-07-31
First posted
2022-04-21
Last updated
2025-05-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05338294. Inclusion in this directory is not an endorsement.